Fibroblast Reprogramming in Gastrointestinal Cancer

Area of Science:

• Gastroenterology and Oncology
• Cancer Biology
• Tumor Microenvironment Research

Background:

• Gastrointestinal cancers cause significant mortality globally, with strong links to chronic inflammation.
• Current treatments target cancer cells, but the tumor microenvironment's role is increasingly recognized.
• Cancer-associated fibroblasts (CAFs) are key players in the tumor microenvironment, influencing cancer initiation, promotion, and metastasis.

Purpose of the Study:

• To review mechanisms of fibroblast reprogramming in cancer.
• To highlight recent advances in signaling pathways regulating activated mesenchymal cells.
• To explore potential new therapeutic strategies targeting CAFs.

Main Methods:

• Literature review of mechanisms driving fibroblast reprogramming.
• Analysis of downstream signaling pathways in activated mesenchyme.
• Synthesis of current understanding of CAF functions in gastrointestinal cancers.

Main Results:

• CAFs, derived from activated mesenchymal cells, are crucial in tumor progression, immunity, angiogenesis, and metastasis.
• Chronic gastrointestinal inflammation drives mesenchymal cell activation and CAF development.
• CAFs can modulate the transition from inflammation to cancer.

Conclusions:

• Understanding fibroblast reprogramming and CAF signaling is vital for developing novel cancer therapies.
• Targeting CAFs and their associated pathways may improve prognosis for gastrointestinal cancer patients.
• Further research into the tumor microenvironment, particularly CAFs, is essential for advancing cancer treatment.